Aspergillosis is an opportunistic fungal infection caused by species of the Aspergillus genus. These are ubiquitous environmental filamentous fungi commonly found in soil, rotting leaves and compost, dust, crops and plants, damp buildings, and air conditioning units.
Aspergillosis is contracted by inhalation of the spores of the Aspergillus fungus into the lungs. However, as an opportunistic pathogen, the spores very rarely cause disease in healthy individuals with fully functioning immune systems. Unfortunately, in the medically vulnerable, particularly those with compromised immune systems, these same spores can multiply, forming fibrous fungal growths in the lungs and can ultimately lead to a serious, often fatal fungal infection called invasive aspergillosis.
sōna Aspergillus Galactomannan Lateral Flow Assay
The IMMY sōna Aspergillus Galactomannan Lateral Flow Assay (Asp GM LFA) is an immunochromatographic test system for the qualitative detection of Aspergillus Galactomannan in serum and bronchoalveolar lavage (BAL) samples.
The Asp GM LFA is a rapid test which, when used in conjunction with other diagnostic procedures such as microbiological culture, histological examination of biopsy samples and radiographic evidence, can be used as an aid in the diagnosis of aspergillosis.
clarus Aspergillus Galactomannan Lateral Flow Assay
The clarus Aspergillus GM EIA is a non-automated immunoenzymatic, sandwich microplate assay that detects Aspergillus galactomannan in serum and BAL samples. It can be used as an aid in the diagnosis of aspergillosis when tested in conjunction with other diagnostic procedures such as microbiological culture, histological examination of biopsy samples, and radiographic evidence.
sõna Aspergillus Galactomannan Lateral Flow Assay
Recommended by guidance from the ECMM for use as part of the initial microbiological diagnostic pathway in all ICU or ARDS ventilation patients and also as part of a continual, tri-weekly screening program for SARS-CoV-2 and Influenza A/B positive patients.
Simple, rapid diagnosis of invasive aspergillosis
Works in synergy with other procedures such as microbiological culture, biopsy histological examination and radiographic evidence, combining to aid in the diagnosis
High sensitivity, specificity and rapid 30-minute test time
Eliminates the need for batch testing and gives results in just 45 minutes
The sõna LFA Cube Reader simplifies the assessment of the intensity of the appearing lines to aid interpretation of results